Infectious Disease Diagnostics – News and Features

The Nobel Prize-winning discovery of the causal link between human papillomavirus (HPV) and cervical cancer has spurred lifesaving prevention technologies – such as HPV testing and HPV vaccines - that are helping to eradicate cervical cancer globally.

PMC appreciates the U.S. FDA’s decision to expand the black box warning on abacavir, a drug used to treat HIV infection.

CE marked under the European In Vitro Diagnostics Directive for the identification of toxigenic Clostridium difficile.

New agreement provides for development and promotion of OraQuick® HCV test outside the United States.

Both technologies are developed by scientists at the University of Colorado at Boulder in close collaboration with the U.S. Centers for Disease Control and Prevention.

LabCorp enters a supply agreement to offer FDA approved COBAS® AmpliPrep/COBAS® TaqMan® HIV-1 Test from Roche Diagnostics.

Dr Aslam will be responsible for all ongoing development programmes within Enigma, with emphasis on Enigma’s rapid diagnostics systems.

The microarray based influenza detection technology is developed by University of Colorado in collaboration with U.S. Centers for Disease Control and Prevention.

Oragenics has filed a U.S. patent application covering a collection of 44 genes of Mycobacterium tuberculosis.

The study demonstrates that eGene's HDA-GT12 Genetic Analyzer can detect H5N1 avian influenza to as few as 10 viral RNA copies.